Anita Brikman: Expanding Access to Plasma-Derived Medicines in India
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”Returning from India on behalf of Plasma Protein Therapeutics Association (PPTA), I look back at an incredibly meaningful- even transformative- journey.
Our time there was centered on listening, learning and strengthening partnerships across a rapidly evolving healthcare ecosystem.
From conversations with regulators and public health leaders to time spent with clinicians, patient advocates, and scientists, it’s clear that progress in expanding access to plasma-derived medicines could be deeply impactful.
I was especially moved by the dedication of individuals who have turned personal experience into advocacy.
Their efforts are helping to build momentum toward a future where more patients with rare and chronic conditions can receive timely and effective treatment with plasma-derived medicines.
While there is still much to be done, the growing collaboration across India signals real opportunity in expanding access to care across the region.
Thank you to the many partners who welcomed us, shared their insights, and continue to push this work forward.
It’s an honor to be part of the life-enabling power of plasma.”

Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause